Board Certified Pharmacotherapy Specialists (BCPSs) and Board Certified Ambulatory Care Pharmacists (BCACPs) seeking live programming to earn recertification credit by continuing education can now register for the Clinical Reasoning Series.
“From Theory to Bedside: Clinical Reasoning Series” and “From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy” are approved by the Board of Pharmacy Specialties for the recertification of BCPSs and BCACPs, respectively. These live educational programs will explore cutting-edge, contemporary topics of relevance to everyday practice and employ active learning exercises designed to advance the skills and abilities of the board-certified specialist. Each program will provide 6.0 CPE credit hours that can be used toward recertification. Both programs will be take place on Saturday, October 20, 2012, in conjunction with the 2012 Annual Meeting in Hollywood, Florida.
Delivered by national experts in their field, the programs will discuss scientific and clinical evidence that help inform individual patient care and formulary decisions. “Antimicrobial Resistance: Prevention and Management Strategies,” designed for the BCPS, will include the following sessions:
- Antimicrobial Resistance: Mechanisms and Emerging Patterns
- Genomics: Strategies Against Resistance Development and Therapeutic Implications
- Methicillin-Resistant Staphylococcus aureus: Microbiology and Clinical Evidence
- Vancomycin-Resistant Enterococcus Infections: Microbiology and Clinical Evidence
- Clostridium difficile Infections: Microbiology and Clinical Evidence
- Antimicrobial Stewardship: Lessons Learned and New Opportunities
- Formulary and Pharmacoeconomic Considerations
“New and Emerging Therapies for the Management of Type 2 Diabetes Mellitus,” designed for the BCACP, will include the following sessions:
- The Science of Diabetes Medications
- New and Emerging Antidiabetic Agents—Scientific and Clinical Evidence
- Management Guidelines—Integrating New Therapeutic Strategies
- Medication Safety—Clinical Considerations and Impact on Health Care
- Formulary and Pharmacoeconomic Considerations
- Pharmacist Services—Patient Outcomes and Best Practices
To be eligible for specialty recertification credits, the specialist must attend the pertinent live program and successfully complete the Web-based posttest for that program by November 30, 2012. More information on both programs and registration details may be found at http://www.accp.com/meetings/am12/.